Polygenic risk score

There are 477 papers on polygenic risk score in aging research: 5 trials and 377 observational studies in people, 63 reviews. The newest story, Nov 9, 2026: “Modeling genetic risk by age improved disease prediction”.

Biomarker

477 papers study it701 more mention it281 findings

135 new papers in 30 daysSee all 1,178 papers on polygenic risk score

“PRS-based risk stratification led to earlier or more intensive screening recommendations in half of the participants”
A clinical pilot study for personalized risk-based breast cancer screening utilizing a polygenic risk scorePloS one2026doi:10.1371/journal.pone.0345431
  • Human trial5
  • Humans377
  • In silico28

Effects

51

Age at screening risk threshold

upin silico1downin silico1

1 study
  1. Polygenic risk score increases age at screening risk threshold in silico (reduced risk individuals (OR<0.5)) (16.8 years later).

    “reduced risk individuals (OR<0.5) 16.8 years later.”

    In silicoreduced risk individuals (OR<0.5)

    Preventing premature deaths through polygenic risk scores

    Nature communications

  2. Polygenic risk score decreases age at screening risk threshold in silico (very high risk individuals (PRS OR>3)) (10.8 years earlier).

    “Very high risk individuals reach the risk level associated with usual starting screening age on average 10.8 years earlier”

    In silicovery high risk individuals (PRS OR>3)

    Preventing premature deaths through polygenic risk scores

    Nature communications

Cognitive prognosis prediction performance

no changein humans1

1 study
  1. Polygenic risk score was not clearly linked with cognitive prognosis prediction performance in humans (Incremental contribution in PRISM-AD; Benjamini-Hochberg correction) (No increment met BH q < 0.05).

    “No PRISM-AD PRS increment met BH q < 0.05.”

    HumansIncremental contribution in PRISM-AD; Benjamini-Hochberg correction

    PRISM-AD quantifies clinical and genetic contributions to cognitive risk prediction

    medRxivPreprint

Cardiovascular risk stratification

upin humans1

1 study
  1. Polygenic risk score improves cardiovascular risk stratification in humans (compared with conventional clinical models) (Net reclassification improvement 3.4% (95% CI 1.5–5.3) to 24.0% (95% CI 18.5–29.5)).

    “PRS-guided risk assessment significantly improved cardiovascular risk stratification compared with conventional clinical models.”

    Reviewcompared with conventional clinical modelsn = 577,289

    Polygenic Risk-Guided Precision Prevention of Atherosclerotic Cardiovascular Disease: A Systematic Review and Network Meta-Analysis of Risk Reclassification and Lipid-Lowering Treatment Benefit

    AHA Scientific Sessions 2026 abstract

Familial systolic blood pressure risk

mediatesin humans1

1 study
  1. Polygenic risk score is linked with familial systolic blood pressure risk in humans (6.6% mediated (95% CI 5.1–8.1) versus 2.0% (0.9–3.0); P<0.001).

    “Familial clustering of CM traits is largely driven by PRS for Lp(a), SBP and CAD, while LSFs dominate for T2DM and BMI.”

    HumansFirst-degree relatives; shared polygenic risk scores versus shared lifestyle and socioeconomic factors

    Quantifying genetic, lifestyle and socioeconomic mediation of familial cardiometabolic risk

    ESC Congress 2026 abstract

Familial coronary artery disease risk

mediatesin humans1

1 study
  1. Polygenic risk score is linked with familial coronary artery disease risk in humans (17.7% mediated (95% CI 9.7–25.8) versus 5.4% (2.1–8.6); P=0.006).

    “Familial clustering of CM traits is largely driven by PRS for Lp(a), SBP and CAD, while LSFs dominate for T2DM and BMI.”

    HumansFirst-degree relatives; shared polygenic risk scores versus shared lifestyle and socioeconomic factors

    Quantifying genetic, lifestyle and socioeconomic mediation of familial cardiometabolic risk

    ESC Congress 2026 abstract

More on Familial coronary artery disease risk

Familial lipoprotein(a) risk

mediatesin humans1

1 study
  1. Polygenic risk score is linked with familial lipoprotein(a) risk in humans (47.1% mediated (95% CI 44.0–50.2) versus 0.1% (0.0–0.2); P<0.001).

    “Mediation via shared high PRS was significantly greater than via shared LSFs for Lp(a)”

    HumansFirst-degree relatives; shared high polygenic risk score versus shared lifestyle and socioeconomic factors

    Quantifying genetic, lifestyle and socioeconomic mediation of familial cardiometabolic risk

    ESC Congress 2026 abstract

More on Familial lipoprotein(a) risk

Obesity prediction model performance

upin humans1

1 study
  1. Polygenic risk score is linked with better obesity prediction model performance in humans (HUA BioResource).

    “with polygenic risk scores (PRSs) enhancing obesity prediction models.”

    HumansHUA BioResource

    The HUA BioResource: A National Infrastructure for Genetic and Phenotypic Insights into BMI and Obesity in Greece

    IEEE journal of biomedical and health informatics

Kidney function decline

no changein humans1

1 study
  1. Polygenic risk score was not clearly linked with kidney function decline in eMERGE or MESA.

    “Neither PRS nor MRS were associated with the rate of decline in kidney function in eMERGE or MESA.”

    Humansin eMERGE or MESA

    Integrated Risk Prediction of Kidney Failure: Clinical and Multi-Omic Approaches

    Clinical journal of the American Society of Nephrology : CJASN

Prediction of metabolic, cardiovascular, autoimmune, and neurological diseases

upin humans1

1 study
  1. Polygenic risk score is linked with better prediction of metabolic, cardiovascular, autoimmune, and neurological diseases in humans (combined with clinical risk models).

    “Genetic information provided the largest predictive gains in metabolic, cardiovascular, autoimmune, and neurological disease”

    Humanscombined with clinical risk models

    Genetic scores add more predictive power at lower clinical risk

    medRxivPreprint

Clinical utility

no changein humans1

1 study
  1. Polygenic risk score showed no clear effect on clinical utility in humans (common adult-onset conditions).

    “polygenic risk scores have had little effect in the clinic.”

    Reviewcommon adult-onset conditions

    Clinical Uses of Common Genetic Variants Associated with Common Diseases

    The New England journal of medicine

Screening recommendations

upin humans1

1 study
  1. Polygenic risk score increases screening recommendations in humans (personalized risk-based screening) (in half of the participants).

    “PRS-based risk stratification led to earlier or more intensive screening recommendations in half of the participants”

    Human trialpersonalized risk-based screeningfemalesn = 80

    A clinical pilot study for personalized risk-based breast cancer screening utilizing a polygenic risk score

    PloS one

All 51

Upstream

1

Sardinian ancestry

downin humans1

1 study
  1. Sardinian ancestry is linked with lower polygenic risk score in humans (SardiNIA project cohort) (0.21 vs. 0.248, p = 1.18 × 10−77).

    “The mean PRS value was significantly lower in Sardinians than in the Europeans (0.21 vs. 0.248, respectively, p = 1.18 × 10−77).”

    HumansSardiNIA project cohortn = 814

    Polygenic risk score and biochemical/environmental variables predict a low-risk profile of age-related macular degeneration in Sardinia

    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

Associations

144

Coronary artery disease

upin humans15HR 1.37–7.1

15 studies
  1. Polygenic risk score is associated with coronary artery disease in humans (Q4 versus Q1 polygenic risk score; association attenuated with age) (Q4-vs-Q1 HR 7.1 at age 45 and 2.5 at age 70; -0.18/yr).

    “For CAD, the observed Q4-vs-Q1 PRS hazard ratio fell from 7.1 at age 45 to 2.5 at age 70 (-0.18/yr);”

    HumansQ4 versus Q1 polygenic risk score; association attenuated with age

    Modeling genetic risk by age improved disease prediction

    AHA Scientific Sessions 2026 abstract

  2. Polygenic risk score is associated with coronary artery disease in humans (High polygenic risk score in index patients) (OR 3.23; 95% CI 2.83–3.69).

    “High PRS in the index patients was significantly associated with all CM traits, including CAD (OR 3.23; 95%CI 2.83-3.69).”

    HumansHigh polygenic risk score in index patients41.2% malesn = 26,796

    Quantifying genetic, lifestyle and socioeconomic mediation of familial cardiometabolic risk

    ESC Congress 2026 abstract

  3. Polygenic risk score predicts coronary artery disease in individuals with chronic kidney disease, accounting for PREVENT risk factors.

    “A PRS of CHD was significantly associated with a 21% hazard of CHD in the PRS+PREVENT risk model (95% CI, [1.06-1.39], 2-sided Wald test P =5.5×10 -3 ).”

    Humansin individuals with chronic kidney disease, accounting for PREVENT risk factors10-year

    Polygenic Risk Scores of Coronary Heart Disease in Chronic Kidney Disease Population: The CRIC Study

    Circulation. Genomic and precision medicine

  4. Polygenic risk score is associated with coronary artery disease in humans (Adjusted subdistribution HR 1.37 per 1 SD; 95% CI 1.21–1.55).

    “Each 1-SD increase in the principal component-adjusted PRS was associated with the primary endpoint (adjusted subdistribution hazard ratio, 1.37; 95% CI, 1.21-1.55; p < 0.001).”

    HumansWithout baseline coronary artery disease; per 1-SD increase in principal component-adjusted polygenic risk scoreMedian follow-up of 6.8 yearsn = 2,067

    Development and internal-external validation of an interpretable machine learning model integrating clinical and polygenic predictors for coronary artery disease: a multicenter retrospective cohort study

    Frontiers in cardiovascular medicine

  5. Polygenic risk score predicts coronary artery disease in humans (combined with age and sex) (AUC 0.910).

    “the PRS models demonstrated strong predictive performance for coronary artery disease, atherosclerosis, and ischemic stroke, with area under the curve values of 0.910, 0.926, and 0.854, respectively.”

    Humanscombined with age and sex

    Evaluation of population-specific polygenic risk scores for blood lipids: insights from Taiwanese cohorts and multiancestry meta-analysis

    Frontiers in bioinformatics

  6. Polygenic risk score is linked with a higher risk of coronary artery disease in individuals with baseline CAC=0 (HR 3.12, 95% CI 1.05-9.31).

    “Individuals in the Top 5% PRS group had higher risk of CAD events compared with the remainder (hazard ratio [HR], 3.12; 95% CI, 1.05-9.31; P=0.041).”

    Humansin individuals with baseline CAC=0

    Prediction of incident coronary artery disease in individuals with zero coronary artery calcium using a novel multi-ancestry, label-free polygenic risk score framework

    medRxivPreprint

  7. Polygenic risk score is associated with coronary artery disease in humans (nonobstructive CAD on coronary angiography) (OR 1.26, 95% CI 1.14-1.39).

    “increasing levels of the polygenic risk score were strongly associated with increased prevalence of nonobstructive and obstructive CAD on coronary angiography (odds ratio, 1.26 [95% CI, 1.14-1.39]”

    Humansnonobstructive CAD on coronary angiography

    Angiographic Burden of Coronary Atherosclerosis Partially Mediates the Association Between ASCVD Risk Factors and Outcomes

    Circulation. Genomic and precision medicine

  8. Polygenic risk score predicts coronary artery disease in humans (White participants with high polygenic risk score).

    “Among White participants, both high PRS and elevated ePWV independently predicted CAD, with a potential mitigating interaction effect.”

    HumansWhite participants with high polygenic risk scoren = 4,741

    Integrating Vascular Aging and Genetic Risk: The Combined Impact of Estimated Pulse Wave Velocity and Genetic Predisposition on Coronary Artery Disease

    Journal of the American Heart Association

  9. Polygenic risk score is linked with a higher risk of coronary artery disease in humans (HR 1.88, 95% CI 1.84–1.91).

    “Each standard deviation (SD) increase in PRS was associated with a 1.88-fold increase in incident CAD risk (95% CI: 1.84, 1.91).”

    Humansn = 409,877

    Interactions Between Polygenic Risk Scores and Social Determinants of Health in Coronary Artery Disease: Insights from the UK Biobank

    AHA Scientific Sessions 2025 abstract

  10. Polygenic risk score is linked with a higher risk of coronary artery disease in humans (positive family history and high polygenic risk score) (OR: 3.26; 95% CI: 3.03 - 3.50).

    “essential hypertension (OR: 2.26; 95% CI: 2.16 - 2.37), and CAD (OR: 3.26; 95% CI: 3.03 - 3.50).”

    Humanspositive family history and high polygenic risk scoren = 103,566

    Impact of Family History and Polygenic Risk Scores on Cardiometabolic Disease Risk

    AHA Scientific Sessions 2025 abstract

All 15

More on Coronary artery disease

Type 2 diabetes

upin humans9OR 1.4–2.25

9 studies
  1. Polygenic risk score predicts type 2 diabetes in humans (cross-ancestry meta-analysis) (AUC = 0.788).

    “constructing a polygenic risk score using the cross-ancestry meta-analysis yielded the most robust predictive performance (AUC = 0.788).”

    Humanscross-ancestry meta-analysis

    East Asian GWAS reveals shared and distinct diabetes pathways

    Communications biology

  2. Polygenic risk score is linked with a higher risk of type 2 diabetes in humans (EPIC-Potsdam cohort).

    “higher MRS, PRS and pPRS predictably indicated higher risk in this population”

    HumansEPIC-Potsdam cohort

    Epigenetic and genetic factors modifying the association between diet quality and incident type 2 diabetes: the EPIC-Potsdam cohort

    Cardiovascular diabetology

  3. Polygenic risk score is linked with a higher risk of type 2 diabetes in humans (African Americans, highest vs lowest tertile) (OR = 1.61; 95% CI:1.22-2.12).

    “African Americans had a higher magnitude of incident T2DM risk for the high-risk PRS alone (OR = 1.61; 95% CI:1.22-2.12) than European Americans”

    HumansAfrican Americans, highest vs lowest tertilen = 1,205

    Ancestry specific polygenic risk score, dietary patterns, physical activity and incident type 2 diabetes

    Human genomics

  4. Polygenic risk score is associated with type 2 diabetes in humans (HR 2.13, 95% CI 2.07–2.18).

    “Higher PRS values were also associated with elevated disease risk, most strongly for T2D (HR 2.13, 95% CI: 2.07 -2.18).”

    Humans

    Evaluating the impact of family history and polygenic risk scores on cardiometabolic disease risk

    BMC medicine

  5. Polygenic risk score is linked with a higher risk of type 2 diabetes in humans (global χ2 p<0.001).

    “Higher polygenic risk quartiles were associated with increased incidence of type 2 diabetes in both cohorts (global χ2 p<0.001).”

    Humans

    Development and validation of a two-stage machine learning model for personalised type 2 diabetes screening in the All of Us Research Program and UK Biobank

    BMJ open

  6. Polygenic risk score is linked with a higher risk of type 2 diabetes in humans (OR: 2.25; 95% CI: 2.18 - 2.33).

    “PRS was independently predictive, with the largest effect seen for T2D (OR: 2.25; 95% CI: 2.18 - 2.33).”

    Humansn = 103,566

    Impact of Family History and Polygenic Risk Scores on Cardiometabolic Disease Risk

    AHA Scientific Sessions 2025 abstract

  7. Polygenic risk score is linked with a higher risk of type 2 diabetes in humans (OR 1.40-1.81, p<6×10-9).

    “a 1-SD increase in the PRS was associated with 40-81% increase in the odds of T2D (i.e., standardized odds ratio [OR] ranging from 1.40-1.81)”

    Humansn = 2,022

    Associations of Polygenic Risk Scores for Type 2 Diabetes with Metabolic Measures in Pacific Islanders from Guam and Saipan

    ADA Scientific Sessions 2025 abstract

  8. Polygenic risk score is linked with a higher risk of type 2 diabetes in humans (per SD) (HR 1.16 (95% CI 1.09-1.22)).

    “Global PRS also associated with T2D risk [HR=1.16 (1.09, 1.22)]”

    Humansper SDn = 2,052

    Partitioned Polygenic Risk Scores (pPRS), Relationship between Insulin Secretion and Sensitivity, and Incidence of Type 2 Diabetes (T2D) in People with Prediabetes

    ADA Scientific Sessions 2025 abstract

  9. Polygenic risk score predicts type 2 diabetes in humans (for diabetes onset and complications).

    “Polygenic risk scores (PRS) can support risk stratification for diabetes onset and complications, but their implementation in Asian populations is limited by reduced cross-population transferability.”

    Reviewfor diabetes onset and complications

    Genetic basis of Asian diabetes

    Journal of diabetes investigation

More on Type 2 diabetes

Prostate cancer

upin humans6OR 1.61–2.19

6 studies
  1. Polygenic risk score is associated with prostate cancer in UK Biobank (p<0.001).

    “Five genes (ATM, BRCA2, CHEK2, HOXB13, MSH2) and the PRS were independently associated with PCa risk (all p<0.001) in UKB.”

    Humansin UK Biobankmalesn = 218,484

    Combined genetic score better distinguishes prostate cancer risk

    Journal of medical genetics

  2. Polygenic risk score is associated with prostate cancer in humans (OR 1.92 (95% CI, 1.72 to 2.13)).

    “A one-unit PRS change was associated with an OR of 1.92 (95% CI, 1.72 to 2.13).”

    Humansmales

    Association of Family History and Polygenic Risk Scores With Prostate Cancer in Africa

    JCO global oncology

  3. Polygenic risk score is linked with a higher risk of prostate cancer in humans (multi-ancestry cohort) (OR 1.61 to 2.19).

    “In ancestry-stratified testing, the PRS showed strong associations with prostate cancer risk, with odds ratios (ORs) per standard deviation (SD) increase ranging from 1.61”

    Humansmulti-ancestry cohort

    Validation and context-dependent effects of a prostate cancer polygenic risk score in the All of Us Research Program

    American journal of human genetics

  4. Polygenic risk score predicts prostate cancer in humans (HR 6.527).

    “Genetic predisposition, assessed by PRS, was a strong independent predictor of prostate cancer (HR for high vs low PRS: 6.527).”

    Humansmalesn = 224,272

    Air Pollution, Lifestyle, and Genetic Risk: A Multidimensional Study of PM2.5 Constituents and Prostate Cancer

    The Journal of urology

  5. Polygenic risk score is associated with prostate cancer in humans (OR 1.80 per SD (95% CI 1.65-1.96)).

    “The PRS was also associated with prevalent prostate cancer (odds ratio = 1.80 per SD (95% CI 1.65-1.96), p < 0.001).”

    Humansmales

    A Polygenic Risk Score Predicts Incident Prostate Cancer Risk in Older Men but Does Not Select for Clinically Significant Disease

    Cancers

  6. Polygenic risk score predicts prostate cancer in humans (HR 1.52 per SD (95% CI 1.33-1.74)).

    “The PRS predicted incident risk with a hazard ratio (HR) of 1.52 per standard deviation (SD) (95% confidence interval (CI) 1.33-1.74, p < 0.001).”

    Humansmedian 4.6 yearsmalesn = 5,701

    A Polygenic Risk Score Predicts Incident Prostate Cancer Risk in Older Men but Does Not Select for Clinically Significant Disease

    Cancers

  7. Polygenic risk score predicts prostate cancer in humans (Asian men in the highest polygenic risk score decile) (4- to 5-fold increased risk in the highest decile).

    “population-specific PRS models effectively stratify prostate cancer risk in Asian men, with individuals in the highest decile showing a 4- to 5-fold increased risk.”

    ReviewAsian men in the highest polygenic risk score decilemales

    Polygenic risk and germline genetics for prostate cancer in Asians: Where do we stand?

    Investigative and clinical urology

More on Prostate cancer

Alzheimer's disease

upin humans6OR 1.14–1.52

6 studies
  1. Polygenic risk score is linked with a higher risk of Alzheimer's disease in humans across four genetic ancestries.

    “Individuals in the extreme upper PRS tail were significantly enriched for AD in all ancestries”

    Humansacross four genetic ancestries

    Extreme polygenic risk scores track high Alzheimer's risk

    medRxiv : the preprint server for health sciencesPreprint

  2. Polygenic risk score predicts Alzheimer's disease in humans across ancestries (AFR: P =2.04×10 − 26 ; AMR: P =4.57×10 −21 ; EAS: P =6.21×10 −40 ; EUR: P =7.90×10 −187).

    “Top-performing PRS were effective at stratifying AD risk across ancestries”

    Humansacross ancestries

    Alzheimer's polygenic risk scores vary widely across models

    medRxiv : the preprint server for health sciencesPreprint

  3. Polygenic risk score is linked with a higher risk of Alzheimer's disease in humans (OR 1.14-1.52 per SD).

    “The PRS was significantly associated with AD in European ancestry, African American, Caribbean Hispanic and Native American Hispanic groups with adjusted odds ratios between 1.14 and 1.52”

    Humans

    A multiancestry polygenic risk score for Alzheimer's disease is associated with cognitive decline and neuropathological hallmarks in diverse populations

    Nature genetics

  4. Polygenic risk score is associated with Alzheimer's disease in humans (high vs low PRS and TRS values) (2.5-fold in ADNI and 3.4-fold in SNUBH).

    “Individuals with high PRS and TRS values showed larger odds ratios for AD, 2.5-fold in ADNI and 3.4-fold in SNUBH, compared to those with low PRS and TRS values.”

    Humanshigh vs low PRS and TRS values

    Integrating polygenic and transcriptional risk scores for detecting Alzheimer's disease

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  5. Polygenic risk score predicts Alzheimer's disease in humans.

    “PRS strongly predicted worse cognitive outcomes and higher AD risk.”

    Humansn = 7,265

    Dynamic Lifestyle Changes Mitigate Alzheimer's Disease Risk Across Genetic Susceptibility

    AAIC 2025 abstract

  6. Polygenic risk score is linked with a higher risk of Alzheimer's disease in humans (impact grows with participant age).

    “Our findings indicate the increased impact of polygenic risk score as participants' age increases.”

    Humansimpact grows with participant age

    Age-dependent effect of APOE and polygenic component on Alzheimer's disease

    Neurobiology of aging

More on Alzheimer's disease

Breast cancer

upin humans5downin humans1OR 0.6–1.8

5 studies
  1. Polygenic risk score predicts breast cancer in women of African ancestry (AUC 0.57 (95% CI: 0.56–0.59)).

    “Overall, PRS models demonstrated modest predictive performance for breast cancer risk in women of African ancestry, with a pooled AUC of 0.57 (95% CI: 0.56–0.59”

    Humansin women of African ancestryfemales

    Performance of Polygenic Risk Scores for Breast Cancer in African Populations: A Systematic Review and Meta-Analysis

    Research SquarePreprint

  2. Polygenic risk score is associated with breast cancer in humans (Chinese women; per 1 SD increase in PRS) (OR 1.64 per 1 SD increase).

    “PRSLRR achieved robust and stable performance across cohorts, yielding an area under the receiver operating characteristic curve (AUC) of 0.633 and an OR of 1.64 per 1 SD increase.”

    HumansChinese women; per 1 SD increase in PRSfemales

    Evaluation of a polygenic risk score for breast cancer in Chinese women: a three-stage case-control study of 13,715 subjects

    Human genomics

  3. Polygenic risk score is linked with a lower risk of breast cancer in humans (≤ 10th percentile) (OR 0.6, p = 1.6 × 10−3).

    “High PRS (≥ 90th percentile) was associated with increased risk (OR 1.8, p = 3.3 × 10−8) and low PRS (≤ 10th percentile) with reduced risk (OR 0.6, p = 1.6 × 10−3) of breast cancer.”

    Humans≤ 10th percentilefemales

    Association of high and moderate penetrance monogenic variants, polygenic risk, and family history with breast cancer in an ancestrally diverse population

    Cancer genetics

  4. Polygenic risk score is linked with a higher risk of breast cancer in humans (≥ 90th percentile) (OR 1.8, p = 3.3 × 10−8).

    “High PRS (≥ 90th percentile) was associated with increased risk (OR 1.8, p = 3.3 × 10−8) and low PRS (≤ 10th percentile) with reduced risk (OR 0.6, p = 1.6 × 10−3) of breast cancer.”

    Humans≥ 90th percentilefemales

    Association of high and moderate penetrance monogenic variants, polygenic risk, and family history with breast cancer in an ancestrally diverse population

    Cancer genetics

  5. Polygenic risk score is linked with a higher risk of breast cancer in humans (highest vs mid PRS deciles) (approximately three times higher risk, highest vs mid deciles).

    “Individuals in the highest PRS decile had approximately three times higher risk compared to those in the mid deciles.”

    Humanshighest vs mid PRS deciles

    Breast cancer risk during oral contraceptive use in women with high polygenic risk

    Breast cancer research : BCR

  6. Polygenic risk score is associated with breast cancer in humans (Black women) (HR1-SD 1.15 (95% CI 0.96-1.38)).

    “A higher PRS was associated with a higher breast cancer risk among White (HR1-SD, 1.48; 95% CI, 1.34-1.65) and Black (HR1-SD, 1.15; 95% CI, 0.96-1.38) women.”

    HumansBlack womenfemales

    Alcohol Consumption Does not Modify the Polygenic Risk Score-Based Genetic Risk of Breast Cancer in Postmenopausal Women: Atherosclerosis Risk in Communities Study

    Cancer prevention research (Philadelphia, Pa.)

  7. Polygenic risk score is linked with a higher risk of breast cancer in humans (White women) (HR1-SD 1.48 (95% CI 1.34-1.65)).

    “A higher PRS was associated with a higher breast cancer risk among White (HR1-SD, 1.48; 95% CI, 1.34-1.65) and Black (HR1-SD, 1.15; 95% CI, 0.96-1.38) women.”

    HumansWhite womenfemales

    Alcohol Consumption Does not Modify the Polygenic Risk Score-Based Genetic Risk of Breast Cancer in Postmenopausal Women: Atherosclerosis Risk in Communities Study

    Cancer prevention research (Philadelphia, Pa.)

More on Breast cancer

Cardiovascular disease

upin humans4mixedin humans1

5 studies
  1. Polygenic risk score is associated with cardiovascular disease in humans.

    “Continuous PRSs were associated with CVD and CHD, but not HF.”

    HumansMedian follow-up of 13.6 years

    Metabolic syndrome, genetic susceptibility, and risk of cardiovascular disease: a prospective study in the UK Biobank

    Frontiers in cardiovascular medicine

  2. Polygenic risk score is linked with a higher risk of cardiovascular disease in humans.

    “These diverging BP trajectories also seem to affect cardiovascular and renal disease risk, with increased risk observed among those in the top decile”

    Humans

    Polygenic risk scores associate with blood pressure traits across the lifespan

    European journal of preventive cardiology

  3. Polygenic risk score predicts cardiovascular disease in humans (as risk-enhancing markers).

    “PRS can identify individuals with elevated lifelong CVD risk, although their current clinical utility is primarily as risk-enhancing markers rather than standalone diagnostic tests.”

    Reviewas risk-enhancing markers

    From Genomics to Precision Cardiology: A Comprehensive Review of Clinical Applications and Challenges in Cardiovascular Diseases

    Clinical cardiology

  4. Polygenic risk score predicts cardiovascular disease in humans.

    “Polygenic risk score (PRS) captures inherited susceptibility and may add precision to guideline-recommended clinical risk score.”

    Review

    Clinical utility of polygenic risk scores in cardiovascular disorders

    Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V

  5. Polygenic risk score is associated with cardiovascular disease in humans.

    “PRS showed a consistent association with cardiovascular events, particularly coronary artery disease.”

    Review

    Potential clinical application of polygenic risk scores in the estimation of cardiovascular risk in primary care; a structured narrative review

    Semergen

More on Cardiovascular disease

Colorectal cancer

upin humans5OR 1.5

5 studies
  1. Polygenic risk score is linked with a higher risk of colorectal cancer in humans (IV-weighted PRS, highest versus lowest tertile, mutually adjusted) (OR = 1.50; 95% CI, 1.10-2.06).

    “IV-weighted PRS: OR = 1.50; 95% CI, 1.10-2.06”

    HumansIV-weighted PRS, highest versus lowest tertile, mutually adjusted

    Integrating polygenic and machine learning-derived nutrient risk scores for colorectal cancer risk stratification: Evidence from Korean adults

    Journal of epidemiology

  2. Polygenic risk score is linked with a higher risk of colorectal cancer in humans (per SD in Europeans) (OR per SD = 2.13, 95% CI 1.98-2.28).

    “The PRS was strongly associated with CRC risk in Europeans (OR per SD =2.13, 95%CI=1.98-2.28)”

    Humansper SD in Europeans

    Genetic prediction of colorectal cancer risk in six major ancestries provides insights to streamline practice screening guidelines

    medRxivPreprint

  3. Polygenic risk score is linked with a higher risk of colorectal cancer in humans (highest vs lowest PRS quintile) (2.69-fold).

    “Individuals in the highest PRS quintile (top 20%) exhibited a 2.69-fold increased CRC risk compared with those in the lowest quintile.”

    Humanshighest vs lowest PRS quintilen = 100,639

    Optimizing colorectal cancer screening through polygenic risk score-based risk stratification: evidence from a population-based cohort and screening trial

    Genome medicine

  4. Polygenic risk score is linked with a higher risk of colorectal cancer in humans (HR 2.40, 95% CI 1.99 to 2.89).

    “The highest quintile of the polygenic risk score was associated with a 2.4-fold increase in CRC risk compared with the lowest quintile (Q5 vs Q1: hazard ratio [HR] = 2.40”

    Humansn = 68,397

    Lifestyle link to colorectal cancer stronger at high genetic risk

    Journal of the National Cancer Institute

  5. Polygenic risk score is linked with a higher risk of colorectal cancer in humans.

    “among all significant risk factors, polygenic risk score (PRS) is the most important risk factor for both age groups.”

    Humans

    Spatial insights into colorectal cancer risk factors and priority areas for screening in the United Kingdom based on data from the UK Biobank

    PloS one

More on Colorectal cancer

Age-related macular degeneration

upin humans4OR 35.13

4 studies
  1. Polygenic risk score predicts age-related macular degeneration in humans (prediction model including LDpred2-based PRS + covariates) (AUC 0.82 (95% CI 0.79-0.85)).

    “A prediction model including LDpred2-based PRS + covariates had an AUC of 0.82 (95% CI 0.79-0.85) and performed better than covariates-only model (P = 5.1 × 10−9).”

    Humansprediction model including LDpred2-based PRS + covariates

    Genome wide association study and genomic risk prediction of age related macular degeneration in Israel

    Scientific reports

  2. Polygenic risk score is linked with a higher risk of age-related macular degeneration in humans (top 5% PRS vs bottom quartile) (1.40-fold, 95% CI 1.04-1.89, p = 0.025).

    “Individuals with the top 5% PRS had a 1.40-fold higher AMD risk compared with that of individuals with a PRS in the bottom quartile (95% CI = 1.04-1.89, p = 0.025).”

    Humanstop 5% PRS vs bottom quartile

    Identification of Genetic Variants for Risk Prediction and Early Diagnosis of Age-Related Macular Degeneration in the Taiwanese Population

    International journal of molecular sciences

  3. Polygenic risk score predicts age-related macular degeneration in humans (compared with PRSs from previously published datasets).

    “significantly improved the prediction accuracy of AMD risk compared with PRSs from previously published datasets.”

    Humanscompared with PRSs from previously published datasets

    Genome-Wide Meta-analysis Identifies Risk Loci and Improves Disease Prediction of Age-Related Macular Degeneration

    Ophthalmology

  4. Polygenic risk score predicts age-related macular degeneration in humans (22-variant model) (AUC = 0.76 (95% CI: (0.72; 0.80))).

    “The diagnostic ability was investigated using ROC analysis with AUC = 0.76 (95% CI: (0.72; 0.80)).”

    Humans22-variant model

    Polygenic Risk Score Impact on Susceptibility to Age-Related Macular Degeneration in Polish Patients

    Journal of clinical medicine

  5. Polygenic risk score is linked with a higher risk of age-related macular degeneration in humans (highest quantile vs lowest reference quantile) (OR = 35.13, 95% CI: (7.9; 156.1), p < 0.001).

    “The patients in the highest quantile had a significantly higher relative risk of developing AMD than those in the lowest reference quantile (OR = 35.13, 95% CI: (7.9; 156.1), p < 0.001).”

    Humanshighest quantile vs lowest reference quantile

    Polygenic Risk Score Impact on Susceptibility to Age-Related Macular Degeneration in Polish Patients

    Journal of clinical medicine

More on Age-related macular degeneration

Atherosclerotic cardiovascular disease

upin humans4OR 1.9

4 studies
  1. Polygenic risk score predicts atherosclerotic cardiovascular disease in humans (atherosclerotic cardiovascular disease) (4.9-fold higher incidence).

    “this reclassified subgroup had 4.9-fold higher incidence during the follow-up than those remaining low-risk.”

    Humansatherosclerotic cardiovascular disease

    Genetic scores add more predictive power at lower clinical risk

    medRxivPreprint

  2. Polygenic risk score is linked with a higher risk of atherosclerotic cardiovascular disease in humans (borderline PREVENT scores (5.0-7.5%)) (OR 1.9).

    “observed 10y ASCVD rate moved from 4.8% (4.0-5.7%) to 8.8% (7.7-10.0%) in low (bottom 20%) versus high (top 20%) PRS individuals, an odds ratio of 1.9”

    Humansborderline PREVENT scores (5.0-7.5%)

    Adding a polygenic risk score to the PREVENT clinical risk tool significantly improves cardiovascular risk prediction

    AHA Scientific Sessions 2025 abstract

  3. Polygenic risk score is linked with a higher risk of atherosclerotic cardiovascular disease in humans (highest tertile compared to lowest tertile) (RR 1.59, 95% CI 1.16–2.17).

    “The high-risk PRS increased ASCVD risk by 59% (Risk Ratio=1.59;95% Confidence Interval:1.16-2.17) in the highest tertile for AAs”

    Humanshighest tertile compared to lowest tertilen = 1,606

    Ancestry Specific Polygenic Risk Score, Dietary Patterns, Physical Activity, and Cardiovascular Disease

    medRxiv : the preprint server for health sciencesPreprint

  4. Polygenic risk score predicts atherosclerotic cardiovascular disease in European populations.

    “Polygenic risk scores (PRS), which quantify this inherited susceptibility, have demonstrated strong predictive performance in European populations, with accumulating evidence supporting their use in clinical practice.”

    Reviewin European populations

    Improving Polygenic Risk Prediction for Atherosclerotic Cardiovascular Disease in East Asian Populations

    JACC. Asia

More on Atherosclerotic cardiovascular disease

Dementia

upin humans4HR 1.18–1.5

4 studies
  1. Polygenic risk score predicts dementia in humans (C+T method with 15 SNPs) (HR 1.18, 95% CI: 1.08-1.28).

    “We found comparable associations between dementia and PRS when comparing a C+T method with only 15 SNPs and PRS derived from Bayesian models that include > 800,000 SNPs (HR5e-08 = 1.18, 95% CI: 1.08-1.28;”

    HumansC+T method with 15 SNPsn = 6,338

    Polygenic Risk Scores for Incident Dementia in the Multi-Ethnic Study of Atherosclerosis

    Genetic epidemiology

  2. Polygenic risk score is linked with a higher risk of dementia in humans (high vs low polygenic risk score) (HR 1.50 (95% CI 1.41–1.60)).

    “The HRs (95% CI) of those with APOE ε4 carriers and high PRS were 3.16 (3.00-3.33) and 1.50 (1.41-1.60), respectively.”

    Humanshigh vs low polygenic risk scoremedian 12.5 years follow-upn = 5,750

    Cardiometabolic diseases, polygenic risk score, APOE genotype, and risk of incident dementia: A population-based prospective cohort study

    Archives of gerontology and geriatrics

  3. Polygenic risk score is linked with a higher risk of dementia in those with low frailty (HR 1.31, 95% CI 1.22 to 1.40).

    “Higher genetic risk was most influential in those with low frailty (HR 1.31, 95% CI 1.22 to 1.40)”

    Humansin those with low frailty

    Frailty, lifestyle, genetics and dementia risk

    Journal of neurology, neurosurgery, and psychiatry

  4. Polygenic risk score is linked with a higher risk of dementia in humans (high versus low polygenic risk score tertile) (1.4-fold (high vs low tertile), CI 1.04-1.76).

    “High PRS tertile was associated with a 1.4-fold dementia risk versus low (CI 1.04-1.76, p = 0.02)”

    Humanshigh versus low polygenic risk score tertile

    Effect of APOE and a polygenic risk score on incident dementia and cognitive decline in a healthy older population

    Aging cell

More on Dementia

Diastolic blood pressure

upin humans2

2 studies
  1. Polygenic risk score predicts diastolic blood pressure in individuals with systemic arterial hypertension (r = 0.84).

    “The resulting PRSs showed strong correlations with both ΔSBP (r = 0.85; p < 0.0001) and ΔDBP (r = 0.84; p < 0.0001).”

    Human trialin individuals with systemic arterial hypertension180 days

    Polygenic risk scores predict blood pressure changes independent of dietary intervention: a secondary analysis of the NUPRESS trial

    European journal of nutrition

  2. Polygenic risk score predicts diastolic blood pressure in humans (incremental R2 +1.4%, p = 0.012).

    “1.4% for DBP (p = 0.012), and 1.1% for mean arterial pressure (MAP) (p = 0.044)”

    Humans

    Pathway-specific polygenic risk scores for blood pressure traits in a West African cohort

    Frontiers in cardiovascular medicine

More on Diastolic blood pressure

Systolic blood pressure

upin humans2

2 studies
  1. Polygenic risk score predicts systolic blood pressure in individuals with systemic arterial hypertension (r = 0.85).

    “The resulting PRSs showed strong correlations with both ΔSBP (r = 0.85; p < 0.0001) and ΔDBP (r = 0.84; p < 0.0001).”

    Human trialin individuals with systemic arterial hypertension180 days

    Polygenic risk scores predict blood pressure changes independent of dietary intervention: a secondary analysis of the NUPRESS trial

    European journal of nutrition

  2. Polygenic risk score predicts systolic blood pressure in humans (incremental R2 +2.6%, p = 0.009).

    “incremental increases in R 2 attributable to the inclusion of PRSs in predictive models were 2.6% for SBP (p = 0.009), 1.4% for DBP (p = 0.012)”

    Humans

    Pathway-specific polygenic risk scores for blood pressure traits in a West African cohort

    Frontiers in cardiovascular medicine

More on Systolic blood pressure

Screening recommendations

upin humans1

1 study
  1. Polygenic risk score is associated with screening recommendations in humans (40 were advised to begin biennial screening before age 50).

    “Polygenic risk score testing may influence current screening recommendations and contribute to more personalized risk-based breast cancer screening strategies.”

    Human trialfemalesn = 80

    A clinical pilot study for personalized risk?based breast cancer screening utilizing the polygenic risk score

    medRxivPreprint

All 144

Funding

37 grants since 2020

National Human Genome Research Institute$12.9MNational Institute on Aging$7.1MNational Heart, Lung, and Blood Institute$2.3M

Latest

Dec 2025: 70Jan 2026: 58Feb 2026: 70Mar 2026: 65Apr 2026: 22May 2026: 25Jun 2026: 29Jul 2026: 47Aug 2026: 60Sep 2026: 80Oct 2026: 96Nov 2026: 61683 papers in 12 months
AHA Scientific Sessions 2026 Abstract

Modeling genetic risk by age improved disease prediction

Across two health-record cohorts, age-varying genetic effects improved one-year prediction for 27 of 28 diseases compared with a model that kept those effects fixed.Across two health-record cohorts, age-varying genetic effects improved one-year prediction for 27 of 28 diseases compared with a model that kept those effects fixed.

Computational studyBiomarkers
AHA Scientific Sessions 2026 Abstract

Chemical markers improved heart and lung disease prediction

Adding 250 chemical markers improved risk models beyond standard clinical measures in an observational study of 54,933 Kaiser Permanente biobank participants.Adding 250 chemical markers improved risk models beyond standard clinical measures in an observational study of 54,933 Kaiser Permanente biobank participants.

Cohort · 54,933 peopleBiomarkers

See all 1,178 papers on polygenic risk score